Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adagio Medical Holdings (ADGM) Goodwill & Intangibles (2024 - 2026)

Adagio Medical Holdings has reported Goodwill & Intangibles over the past 3 years, most recently at $20.9 million for Q1 2026.

  • Quarterly Goodwill & Intangibles changed 0.0% to $20.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $20.9 million through Mar 2026, changed 0.0% year-over-year, with the annual reading at $20.9 million for FY2025, 47.88% down from the prior year.
  • Goodwill & Intangibles was $20.9 million for Q1 2026 at Adagio Medical Holdings, roughly flat from $20.9 million in the prior quarter.
  • Over five years, Goodwill & Intangibles peaked at $48.3 million in Q3 2024 and troughed at $20.9 million in Q1 2025.
  • The 3-year median for Goodwill & Intangibles is $20.9 million (2025), against an average of $27.6 million.
  • Year-over-year, Goodwill & Intangibles plummeted 56.62% in 2025 and then changed 0.0% in 2026.
  • A 3-year view of Goodwill & Intangibles shows it stood at $40.2 million in 2024, then tumbled by 47.88% to $20.9 million in 2025, then changed by 0.0% to $20.9 million in 2026.
  • Per Business Quant, the three most recent readings for ADGM's Goodwill & Intangibles are $20.9 million (Q1 2026), $20.9 million (Q4 2025), and $20.9 million (Q3 2025).